100 related articles for article (PubMed ID: 1643153)
21. Adoptive T-cell therapy improves treatment of canine non-Hodgkin lymphoma post chemotherapy.
O'Connor CM; Sheppard S; Hartline CA; Huls H; Johnson M; Palla SL; Maiti S; Ma W; Davis RE; Craig S; Lee DA; Champlin R; Wilson H; Cooper LJ
Sci Rep; 2012; 2():249. PubMed ID: 22355761
[TBL] [Abstract][Full Text] [Related]
22. Serological thymidine kinase 1 is a biomarker for early detection of tumours--a health screening study on 35,365 people, using a sensitive chemiluminescent dot blot assay.
Chen ZH; Huang SQ; Wang Y; Yang AZ; Wen J; Xu XH; Chen Y; Chen QB; Wang YH; He E; Zhou J; Skog S
Sensors (Basel); 2011; 11(12):11064-80. PubMed ID: 22247653
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in chronic lymphocytic leukemia-what do we need to know?
Cramer P; Hallek M
Nat Rev Clin Oncol; 2011 Jan; 8(1):38-47. PubMed ID: 20956983
[TBL] [Abstract][Full Text] [Related]
24. 3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.
Lin J; Roy V; Wang L; You L; Agrofoglio LA; Deville-Bonne D; McBrayer TR; Coats SJ; Schinazi RF; Eriksson S
Bioorg Med Chem; 2010 May; 18(9):3261-9. PubMed ID: 20378362
[TBL] [Abstract][Full Text] [Related]
25. Serum thymidine kinase 1 concentration in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors.
Xu W; Cao X; Miao KR; Qiao C; Wu YJ; Liu Q; Fan L; Li JY
Int J Hematol; 2009 Sep; 90(2):205-211. PubMed ID: 19629630
[TBL] [Abstract][Full Text] [Related]
26. The role of DNA synthesis imaging in cancer in the era of targeted therapeutics.
Nimmagadda S; Shields AF
Cancer Metastasis Rev; 2008 Dec; 27(4):575-87. PubMed ID: 18512023
[TBL] [Abstract][Full Text] [Related]
27. Influence of dTMP on the phenotypic appearance and intracellular persistence of Staphylococcus aureus.
Zander J; Besier S; Saum SH; Dehghani F; Loitsch S; Brade V; Wichelhaus TA
Infect Immun; 2008 Apr; 76(4):1333-9. PubMed ID: 18160477
[TBL] [Abstract][Full Text] [Related]
28. Interaction of human thymidine kinase 1 with p21(Waf1).
Huang DY; Chang ZF
Biochem J; 2001 Jun; 356(Pt 3):829-34. PubMed ID: 11389691
[TBL] [Abstract][Full Text] [Related]
29. dNTP pools imbalance as a signal to initiate apoptosis.
Oliver FJ; Collins MK; López-Rivas A
Experientia; 1996 Oct; 52(10-11):995-1000. PubMed ID: 8917730
[TBL] [Abstract][Full Text] [Related]
30. Plasma cell proliferation in monoclonal gammopathies: measurement using BU-1 antibody in flow cytometry and microscopy: comparison with serum thymidine kinase.
Schambeck CM; Wick M; Bartl R; Lamerz R; Fateh-Moghadam A
J Clin Pathol; 1995 May; 48(5):477-81. PubMed ID: 7629298
[TBL] [Abstract][Full Text] [Related]
31. Thymidine kinases: the enzymes and their clinical usefulness.
Hannigan BM; Barnett YA; Armstrong DB; McKelvey-Martin VJ; McKenna PG
Cancer Biother; 1993; 8(3):189-97. PubMed ID: 7804359
[TBL] [Abstract][Full Text] [Related]
32. [The enzymatic character of myeloma cell].
Yoshikawa O; Furuya T; Toyama K
Nihon Rinsho; 1995 Mar; 53(3):598-602. PubMed ID: 7699891
[TBL] [Abstract][Full Text] [Related]
33. Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications.
Hallek M; Wanders L; Strohmeyer S; Emmerich B
Ann Hematol; 1992 Jul; 65(1):1-5. PubMed ID: 1643153
[TBL] [Abstract][Full Text] [Related]
34. Serum thymidine kinase activity: an alternative to histologic markers of cellular proliferation in canine lymphoma.
Madewell BR
J Vet Intern Med; 2004; 18(5):595-6. PubMed ID: 15515571
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study of the prognostic role of serum thymidine kinase level in CLL patients with active disease treated with fludarabine.
Di Raimondo F; Giustolisi R; Lerner S; Cacciola E; O'Brien S; Kantarjian H; Keating MJ
Ann Oncol; 2001 May; 12(5):621-5. PubMed ID: 11432619
[TBL] [Abstract][Full Text] [Related]
36. Thymidine kinase as a proliferative marker: clinical relevance in 1,692 primary breast cancer patients.
Broët P; Romain S; Daver A; Ricolleau G; Quillien V; Rallet A; Asselain B; Martin PM; Spyratos F
J Clin Oncol; 2001 Jun; 19(11):2778-87. PubMed ID: 11387348
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]